Phenotypic drug susceptibility testing is a valuable tool to guide therapy in rapid growing mycobacteria. Beta lactams, however, exhibit insufficient stability during a 5-day incubation period in minimal inhibitory concentration (MIC) testing as well as in time kill kinetics experiments. This might lead to false minimal inhibitory concentrations and inadequate therapeutic decisions.